IL22 and psoriasis: This interruption in cytokine signaling effectively reduces the inflammatory response mediated by cytokines such as IL-4, IL-13, IL-31, IL-22, and IFN-γ, which are critical in conditions like AD, psoriasis, and alopecia areata (AA) (24).